Detalhe da pesquisa
1.
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma.
Blood;
140(23): 2463-2476, 2022 12 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35960849
2.
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia.
Blood;
134(16): 1323-1336, 2019 10 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31492675
3.
Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL.
Blood;
131(4): 421-425, 2018 01 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29187379
4.
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.
Nat Commun;
12(1): 3705, 2021 06 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34140493
5.
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer.
Nat Med;
27(5): 820-832, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33958794
6.
EML1-ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant Model.
Hemasphere;
2(2): e32, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31723760
7.
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Cancer Cell;
34(2): 271-285.e7, 2018 08 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30107177
8.
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.
Cancer Discov;
8(5): 616-631, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29496663